Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,546
Recruiting: 1,932
Ph III recruiting: 225
Growth YoY: +16.4%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 201–235 of 235 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06577961	Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients	not yet recruiting	Phase 1 / Phase 2	37	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	0	Aug 29, 2024	clinicaltrials
NCT06574412	Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.	not yet recruiting	Phase 2	30	The First Hospital of Jilin UniversityOTHER	0	Aug 28, 2024